rs10404453

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The ENST00000602324.1(SPACA6-AS1):​n.222C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00323 in 647,306 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0091 ( 16 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 9 hom. )

Consequence

SPACA6-AS1
ENST00000602324.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.127

Publications

10 publications found
Variant links:
Genes affected
SPACA6-AS1 (HGNC:49383): (SPACA6 antisense RNA 1)
SPACA6 (HGNC:27113): (sperm acrosome associated 6) Predicted to be involved in fusion of sperm to egg plasma membrane involved in single fertilization. Predicted to be located in acrosomal vesicle. [provided by Alliance of Genome Resources, Apr 2022]
MIR125A (HGNC:31505): (microRNA 125a) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00912 (1387/152040) while in subpopulation AFR AF = 0.0312 (1296/41474). AF 95% confidence interval is 0.0298. There are 16 homozygotes in GnomAd4. There are 639 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPACA6NM_001316972.2 linkc.-292G>A upstream_gene_variant ENST00000637797.2 NP_001303901.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPACA6ENST00000637797.2 linkc.-292G>A upstream_gene_variant 1 NM_001316972.2 ENSP00000490829.1

Frequencies

GnomAD3 genomes
AF:
0.00906
AC:
1376
AN:
151920
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0311
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00261
AC:
475
AN:
182214
AF XY:
0.00185
show subpopulations
Gnomad AFR exome
AF:
0.0329
Gnomad AMR exome
AF:
0.00267
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000140
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000250
Gnomad OTH exome
AF:
0.00125
GnomAD4 exome
AF:
0.00142
AC:
703
AN:
495266
Hom.:
9
Cov.:
0
AF XY:
0.00114
AC XY:
303
AN XY:
265192
show subpopulations
African (AFR)
AF:
0.0314
AC:
474
AN:
15098
American (AMR)
AF:
0.00288
AC:
98
AN:
34016
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17530
East Asian (EAS)
AF:
0.000138
AC:
4
AN:
28958
South Asian (SAS)
AF:
0.0000656
AC:
4
AN:
60968
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
44946
Middle Eastern (MID)
AF:
0.00380
AC:
14
AN:
3684
European-Non Finnish (NFE)
AF:
0.000151
AC:
40
AN:
264070
Other (OTH)
AF:
0.00265
AC:
69
AN:
25996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00912
AC:
1387
AN:
152040
Hom.:
16
Cov.:
32
AF XY:
0.00860
AC XY:
639
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.0312
AC:
1296
AN:
41474
American (AMR)
AF:
0.00373
AC:
57
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4798
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
67972
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00457
Hom.:
3
Bravo
AF:
0.0107
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
5.9
DANN
Benign
0.63
PhyloP100
0.13
PromoterAI
0.035
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10404453; hg19: chr19-52196488; API